| Application no. and date | 11725494.6 (espacenet) (Federated) (European Patent Register), 20110609 | | Patent/reg. no. and date | DK/EP 2579877, 20140813 | | Publication date | 20130417 | | Priority no. and date | US 353713 P, 20100611 | | EP pub. no. and date |
EP 2579877 20130417 | | Effective date | | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | Astra 103985-EP-EPT | | Inventor | FOOTE, Kevin, Michael, AstraZeneca R & D Alderley
Alderley Park
Macclesfield, Cheshire SK10 4TG, GB,
NISSINK, Johannes, Wilhelmus, Maria, AstraZeneca R&D Alderley
Alderley Park
Macclesfield, Cheshire SK10 4TG, GB,
TURNER, Paul, AstraZeneca R&D Alderley
Alderley Park
Macclesfield, Cheshire SK10 4TG, GB | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/505 (2006.01) , A61P 35/00 (2006.01) , C07D 413/14 (2006.01) , C07D 471/04 (2006.01) | | Title | MORPHOLINOPYRIMIDINER OG DERES ANVENDELSE TIL TERAPI | | Int. application no. | GB2011051074 | | Int. publication no. | WO2011154737 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
